Gafos Mitzy, Mzimela Misiwe A, Ndlovu Hlengiwe B, McCormack Sheena, McGrath Nuala
The Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.
AIDS Care. 2013;25(5):573-8. doi: 10.1080/09540121.2012.722604. Epub 2012 Sep 13.
To assess the views of potential end-users of a microbicide in KwaZulu-Natal regarding the characteristics that would justify further development, three focus group discussions were conducted in 2009 with 23 local staff members working on a microbicide clinical trial, 20 former trial participants and 14 Community Advisory Board members not enrolled in the trial, in an area with high HIV incidence and low consistent condom use. All participants agreed on the need for additional HIV prevention options that are as effective as possible and can be used by women. The majority of respondents stated that even a highly acceptable HIV prevention option with protection as low as 30% would still be an important addition to condoms for women; that a partially protective microbicide would have to be introduced as part of the existing prevention messages in order to continue promoting condom use; that there should eventually be a choice between antiretroviral (ARV) and non-ARV-based microbicides and a choice of how and where to access microbicides. Respondents also felt it would be important to make plans for access to a microbicide that can offer protection, even if partial, rather than wait to find out if alternative microbicides are equally or more effective. Potential end-users in a high HIV prevalence area believe that a partially effective microbicide would be an important addition to the limited HIV prevention options for women. The significant challenges of introducing a partially protective HIV prevention option were recognised, but seen as ones worth facing, as well as an opportunity to lay the ground work for the introduction of more efficacious HIV prevention methods in the future.
为了评估夸祖鲁 - 纳塔尔省一种杀微生物剂潜在终端用户对于那些能够证明进一步研发合理性的特性的看法,2009年开展了三场焦点小组讨论,参与者包括23名参与杀微生物剂临床试验的当地工作人员、20名前试验参与者以及14名未参与试验的社区咨询委员会成员,该地区艾滋病毒感染率高且避孕套持续使用率低。所有参与者都认同需要有更多尽可能有效的艾滋病毒预防选择,并且这些选择要可供女性使用。大多数受访者表示,即使是一种接受度很高但保护率低至30%的艾滋病毒预防选择,对女性而言仍是避孕套之外的一项重要补充;一种具有部分保护作用的杀微生物剂必须作为现有预防信息的一部分引入,以便继续推广避孕套的使用;最终应该在基于抗逆转录病毒药物(ARV)和非ARV的杀微生物剂之间做出选择,以及在如何获取和何处获取杀微生物剂方面做出选择。受访者还认为,即便杀微生物剂只能提供部分保护,也要制定获取计划,而不是等着看其他杀微生物剂是否同样有效或更有效,这一点很重要。艾滋病毒高流行地区的潜在终端用户认为,一种部分有效的杀微生物剂将是女性有限的艾滋病毒预防选择中的一项重要补充。引入一种具有部分保护作用的艾滋病毒预防选择所面临的重大挑战是公认的,但这些挑战被视为值得面对,同时也是为未来引入更有效的艾滋病毒预防方法奠定基础的一个契机。